FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreNational Government Services (NGS), a Medicare Administrative Contractor (MAC), proposed a Local Coverage Determination (LCD) that would deny Medicare coverage for Automated Detection and Quantification of Brain MRI technologies (CPT codes 0865T and 0866T). The draft policy would affect clinical practices in Illinois, Minnesota, Wisconsin, Connecticut, New York, Maine, Massachusetts, New Hampshire, Rhode Island and Vermont.
The proposed LCD (DL40332) and accompanying billing article (DA60398) are now open for public comment through March 8. ACR® encourages members, particularly Neuroradiologists who use these emerging AI enabled MRI tools to review the proposals and consider submitting comments.
NGS will host a public open meeting Feb. 26, 12–2pm ET, to discuss the draft LCD and hear presentations from clinicians, stakeholders and the public. Registration details and the meeting agenda are available online. Anyone wishing to present must submit a written request by Feb. 12.
Celerian Group Company Administrators, LLC, the MAC serving Ohio and Kentucky, stopped covering these services Jan. 19. The MAC’s final LCD and supporting rationale are available to the public.
For more information about LCD activities or questions, contact Alicia Blakey, ACR Manager, Economic Policy.
FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreLower Fee Now in Effect to File No Surprises Act Disputes
Federal agencies released a final rule that updates the No Surprises Act independent dispute resolution process. The rule lowers the IDR administrative or filing fee from $115 to $15.
Read moreACR Urges Funding for NIH All of Us Program
ACR urges Congress to provide dedicated funding for NIH’s All of Us Research Program, a leader in precision medicine technologies and a valuable tool for researchers.
Read more